RecruitingNCT07604220

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

Sponsor

Mayo Clinic

Enrollment

115 participants

Start Date

Jul 13, 2026

Study Type

OBSERVATIONAL

Conditions

Cardiac Sarcoidosis Sarcoidosis With Myocarditis Sarcoidosis of the Heart Sarcoidosis, Cardiac

Summary

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Exosome Analysis for people with cardiac sarcoidosis, sarcoidosis with myocarditis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExosome Analysis

Blood Samples will undergo exosome profiling using mass spectrometry and/or other discovery-based approaches

Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07604220

Related Trials

A Prospective Diagnostic Trial of Al[¹⁸F]F-NOTA-folate PET in Patients With Suspected Cardiac Sarcoidosis and Infective Endocarditis

NCT07814222

Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition

NCT064095851 location